Navigation Links
At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better
Date:9/3/2008

FAIRFAX, Va.Ten million Americans have peripheral arterial disease (PAD), and research shows that the highest risk populations include African-Americans (twice as likely to develop clogged leg arteries), seniors (12-20 percent develop PAD) and diabetics (one in three who are over the age of 50 develop PAD). Legs for Lifea community health and public information programrecommends that older Americans take its free, online self-assessment quiz.

The online quiz (www.legsforlife.org) helps assess health, family and lifestyle risks for PAD. The higher one's score, the more important it is for that individual to discuss the quiz's results with his or her doctor. Additionally, Legs for Life offers a free national screening program dedicated to improving the cardiovascular health of the community with the early detection of PAD.

"Early detection and management of peripheral arterial disease, or PAD, can prevent its progression and help prevent painful walking, gangrene, amputation, heart attack or stroke," said interventional radiologist Timothy P. Murphy, M.D., Legs for Life chair. "Older men and women need to be examined with the ankle brachial index (ABI) test that can diagnose PAD. Individuals need to know their ABI number the way they know their cholesterol, blood pressure or blood sugar number; it can save their lives," added Murphy.

African-Americans are twice as likely to develop PAD, with their increased risk making them as vulnerable as someone who smoked a pack of cigarettes a day for 20 years, explained Murphy. Seniors may typically dismiss warning symptoms as signs of getting older; however, just like clogged arteries in the heart, clogged arteries in the legs mean that one could be at risk for heart attack or stroke. And, individuals with diabetes are especially susceptible to PAD because diabetes affects every vascular bed in the body and increases the risk for accelerated atherogenesisthe formation of plaque build up in the lining of the arteriesplacing 18.2 million Americans at risk, he noted. "The public at largeas well as the medical communityneed to appreciate the importance of the diagnosis of PAD in terms of symptoms and avoiding amputation, but also importantly in how a diagnosis of PAD entails added risk of heart attack, stroke and death," noted Murphy.

PAD develops mostly as a result of atherosclerosis, a condition that occurs when cholesterol and scar tissue build up, forming a substance called plaque, which narrows and clogs the arteries and slows blood flow to the legs. Since plaque blocks the smaller leg arteries first, PAD is considered a red flag for several life-threatening vascular diseases, such as heart attack (the number one killer in this country) and stroke. Symptomssuch as leg pain while walking, numbness and tingling in the lower legs and feet, coldness in the lower legs and feet, or ulcers or sores on the legs or feet that don't healcould be PAD warning signs. The disease's progression results in death for about one-third of patients.

With early detection, patients could be sent to an interventional radiologist sooner when intervention is most effective and less invasive treatments are an option. In many cases, PADand its progressioncan be treated with medication, lifestyle changes (such as smoking cessation), diet and a structured exercise program. If needed, interventional radiologists can perform minimally invasive angioplasty and/or stenting to open a blocked artery in the leg and restore blood flow.

In September, free testing is available for PAD at nearly 100 Legs for Life sites around the country. The ABI, a simple and painless test, compares the blood pressure in the legs to the blood pressure in the arms to determine how well the blood is flowing and if additional tests are needed. More than 322,000 people have been screened to date, with one in four at risk for PAD. Select sites will also screen for abdominal aortic aneurysm, stroke and venous disease.

While more than 50 percent of PAD patients may not show signs of the disease, screening is essential for diagnosis. Individuals should be tested if they

  • Have cramping in your leg when walking or exercising that is relieved by resting
  • Are over age 50
  • Have high cholesterol, a high lipid blood test or high blood pressure
  • Have a family history of vascular disease, such as PAD, aneurysm, heart attack or stroke
  • Have diabetes
  • Smoke now or have ever smoked
  • Are African-American
  • Are overweight

    "As vascular experts, interventional radiologists can intervene early, help prevent vascular disease progression and provide minimally noninvasive treatment if needed," said Murphy. Legs for Life began a decade ago because interventional radiologists recognized that the disease is a major public health problem with a growing incidence, yet awareness among the general public and nonvascular health care providers is low.

    To take the free PAD risk assessment quiz to review the results with one's own doctoror to request a screening appointmentvisit www.legsforlife.org. Note: Legs for Life sites provide a limited number of screenings; advance appointments are required. Many interventional radiologists offer year-round screening by appointment; a link to this information is provided on the Legs for Life site.


    '/>"/>


  • Contact: Maryann Verrillo
    mverrillo@SIRweb.org
    703-460-5572
    Society of Interventional Radiology
    Source:Eurekalert

    Related biology news :

    1. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
    2. Engineer develops detergent to promote peripheral nerve healing
    3. Lipids in the brain an important factor for Alzheimers disease?
    4. Microbial stowaways: Are ships spreading disease?
    5. Safe water: simpler method for analyzing radium in water samples cuts testing time
    6. Gene regulation in humans is closer than expected to simple organisms
    7. Researchers develop simple method to create natural drug products
    8. Simple reason helps males evolve more quickly
    9. Simple recipe turns human skin cells into embryonic stem cell-like cells
    10. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
    11. Salt-tolerant gene found in simple plant nothing to sneeze at
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
    (Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
    (Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
    Breaking Biology News(10 mins):
    (Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
    (Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
    (Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
    (Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
    Breaking Biology Technology: